These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25562449)

  • 1. Discriminating between latent and active tuberculosis: the role of interleukin-2 as biomarker.
    Mamishi S; Pourakbari B; Marjani M; Bahador A; Mahmoudi S
    J Infect; 2015 Apr; 70(4):429-31. PubMed ID: 25562449
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma cytokines and chemokines differentiate between active disease and non-active tuberculosis infection.
    Mihret A; Bekele Y; Bobosha K; Kidd M; Aseffa A; Howe R; Walzl G
    J Infect; 2013 Apr; 66(4):357-65. PubMed ID: 23178506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplex analysis of plasma cytokines/chemokines showing different immune responses in active TB patients, latent TB infection and healthy participants.
    Yao X; Liu Y; Liu Y; Liu W; Ye Z; Zheng C; Ge S
    Tuberculosis (Edinb); 2017 Dec; 107():88-94. PubMed ID: 29050777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis: which drug regimen and when.
    Hall J; Elliott C
    J Fam Pract; 2015 Jan; 64(1):27-33. PubMed ID: 25574509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
    Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
    J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects.
    Hur YG; Kang YA; Jang SH; Hong JY; Kim A; Lee SA; Kim Y; Cho SN
    J Infect; 2015 Apr; 70(4):346-55. PubMed ID: 25452040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis testing: Which patients, which test?
    Elliott C; Hall J
    J Fam Pract; 2015 Sep; 64(9):553-65. PubMed ID: 26546956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of active and latent tuberculosis: summary of NICE guidance.
    Abubakar I; Griffiths C; Ormerod P;
    BMJ; 2012 Oct; 345():e6828. PubMed ID: 23077351
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical forms and treatment of tuberculosis in children].
    Donato L; Mansilla M
    Soins Pediatr Pueric; 2012; (264):17-20. PubMed ID: 22420075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-induced cytokine and chemokine release test for tuberculosis infection using adsorption of stimulated whole blood on filter paper and multiplex analysis.
    Skogstrand K; Thysen AH; Jørgensen CS; Rasmussen EM; Andersen AB; Lillebaek T; Hougaard DM; Houen G
    Scand J Clin Lab Invest; 2012 May; 72(3):204-11. PubMed ID: 22283828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
    Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
    Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivation tuberculosis: role of surveillance.
    DiNardo AR; Guy E
    Expert Rev Anti Infect Ther; 2016; 14(5):501-9. PubMed ID: 27042967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In reply: Latent TB treatment in pregnant women: a patient perspective.
    Dhamgaye TM
    Int J Tuberc Lung Dis; 2020 Nov; 24(11):1226-1227. PubMed ID: 33172537
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnosis and treatment of tuberculosis infection: can it contribute to achieving tuberculosis elimination?
    Matteelli A; Alffenaar JC
    Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 35798372
    [No Abstract]   [Full Text] [Related]  

  • 15. Tuberculosis: an overview.
    Cruz-Knight W; Blake-Gumbs L
    Prim Care; 2013 Sep; 40(3):743-56. PubMed ID: 23958367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacteria-specific cytokine responses as correlates of treatment response in active and latent tuberculosis.
    Clifford V; Tebruegge M; Zufferey C; Germano S; Forbes B; Cosentino L; McBryde E; Eisen D; Robins-Browne R; Street A; Denholm J; Curtis N
    J Infect; 2017 Aug; 75(2):132-145. PubMed ID: 28483404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune parameters differentiating active from latent tuberculosis infection in humans.
    Lee JY; Jung YW; Jeong I; Joh JS; Sim SY; Choi B; Jee HG; Lim DG
    Tuberculosis (Edinb); 2015 Dec; 95(6):758-763. PubMed ID: 26520601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy.
    Wergeland I; Pullar N; Assmus J; Ueland T; Tonby K; Feruglio S; Kvale D; Damås JK; Aukrust P; Mollnes TE; Dyrhol-Riise AM
    J Infect; 2015 Apr; 70(4):381-91. PubMed ID: 25597826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplex analysis of cytokines/chemokines as biomarkers that differentiate healthy contacts from tuberculosis patients in high endemic settings.
    Anbarasu D; Raja CP; Raja A
    Cytokine; 2013 Mar; 61(3):747-54. PubMed ID: 23395386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Present-day treatment of tuberculosis and latent tuberculosis infection.
    Pérez-Camacho I; Rivero-Juárez A; Kindelán JM; Rivero A
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():41-6. PubMed ID: 21420566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.